QIAGEN has acquired Genoox, adding Franklin—its powerful, AI-driven genomic interpretation platform—to the QIAGEN Digital Insights portfolio. By uniting Franklin’s real-time NGS analysis and community-driven data with QIAGEN’s expert-curated databases like HGMD and HSMD, we’re advancing precision medicine with faster, smarter insights for better patient outcomes.
Deployed in 44 countries and 1,700 organizations
Created for professionals, by professionals, Franklin is the world’s first open genomic community. Our users leverage its vendor-neutral, workflow-agnostic platform to generate data insights across the entire genomic value chain.
Franklin's genomic insights are based on real-world evidence that is fused with publicly available data, impacting lives by making genomic data accessible and actionable at the point of care.
Harnessing the power of community, Franklin is building the world’s largest, most diverse real-world evidence dataset to answer any genomic question.
Our community of users, the data they share, and our powerful interpretation engine create actionable genomic insights that guide clinical decisions, accelerate care pathways and enable targeted therapies.
Franklin’s open genomic community is a global, collaborative network that accelerates genomic interpretation.
Leveraging both community-generated and proprietary data, Franklin by QIAGEN is an AI-powered genomic analytics solution that streamlines the path from DNA sample to clinical report. The cloud-based AI framework and indication agnostic platform enable genomic professionals to easily manage the entire genetic sequencing process.
A fully modular pipeline that enables selection of relevant tools to maximize the efficiency and accuracy of your NGS pipeline.
AI-based variant classification leveraging any publicly available data source to suggest relevant evidence, address gene-specific recommendation and deliver fully transparent ACMG/AMP-based variant classifications.
Prioritizes and aggregates frequently updated information from published research, new and existing archives, and curated and uncurated databases; filters out “noise” and highlights evidence crucial to decision-making.
Custom content integration helps organizations build a centralized, in-platform knowledge base to integrate and analyze their own curated genetic data and clinical evidence.
With integrated secondary and tertiary analysis in one platform, Franklin by QIAGEN streamlines the entire analysis, interpretation and reporting process.
Supports CMA, CGH, and long-read sequencing by providing flexible data import, robust variant interpretation tools, and customizable workflows tailored to handle structural variants, copy number changes, and complex genomic regions.
Ideal for labs performing WES/WGS for hereditary applications because it offers streamlined, AI-powered variant interpretation, automated ACMG classification, and customizable workflows tailored for rare disease analysis.
Franklin by QIAGEN offers both Free and Premium access levels, designed to meet the needs of individual users and institutional teams. Whether you're exploring genomic data independently or managing complex workflows at scale, Franklin delivers the tools you need to power precision medicine.
Ideal for individual clinicians, genetic counselors, and researchers looking to explore, interpret, and share genomic insights.
Designed for laboratories, hospitals, and research teams needing advanced tools, scalability, and institutional collaboration.
If you’d like to chat about Franklin by QIAGEN in more detail, complete this form and we’ll get back to you.
